1.33
price down icon3.96%   -0.06
 
loading

なぜErasca Inc(ERAS)の株価が下がっていますか?

2025-04-10 の取引セッション中に、Erasca Inc (ERAS) 株の 10.88% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-11-28:

Shares of Erasca Inc (ERAS) dropped by 11.38% from $2.24 to $1.99 in the trading on Tuesday, November 28, 2023. The reason why ERAS is down today is due to the company's program updates, particularly regarding its SEACRAFT-2 Phase 3 trial for Naporafenib Plus Trametinib and its THUNDERBBOLT-1 Phase 1 trial for ERAS-801. Investors may have been concerned about the trial details, including the patient population and comparator arm in SEACRAFT-2, as well as the need for additional data for ERAS-801. Additionally, the company's decision to deprioritize certain programs and focus on more promising initiatives could have contributed to the stock's decline.

$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
大文字化:     |  ボリューム (24 時間):